Evommune EVMN Growth Metrics (2024-2026)

NYSE EVMN
$12.27 +0.27 (+2.25%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Evommune Quarterly Growth Metrics

Periods 7 quarters
Latest Jun 2026

Evommune growth metrics data for the quarter ended Jun 2026. These growth metrics cover 7 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

1Y3Y5Y7Y10YAll
Download Data
Growth Metrics Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y) 195.77%
Assets (QoQ) 166.07%43.35%-6.36%
Capital Expenditures (QoQ)Capex (QoQ) -20.61%-20.19%120.48%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 47.79%171.07%747.09%-2.92%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) -10.42%-64.91%984.10%-56.63%64.30%9.66%24.25%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y) -271.53%-732.29%73.86%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ) 140.81%33.33%-232.81%-414.10%30.55%136.66%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) 9.79%-15.08%22.48%
Cash from Operations (QoQ)Cash from Ops. (QoQ) -29.10%-9.66%63.24%-73.32%-64.70%26.13%
EBIT Growth (1y) 19.31%-38.51%-59.35%-51.76%
EBIT (QoQ) -29.89%29.93%-52.97%42.04%-122.96%19.39%-45.68%
EBT Growth (1y) 21.62%-36.41%-50.18%-42.57%
EBT (QoQ) -30.22%30.37%-56.72%44.84%-126.64%23.34%-48.78%
EPS (Basic) Growth (1y) 22.85%66.47%93.15%93.92%
EPS (Basic) (QoQ) -31.30%31.58%-56.14%45.00%42.94%86.03%-38.63%
EPS (Diluted) Growth (1y) 22.85%66.47%93.15%93.92%
EPS (Diluted) (QoQ) -31.30%31.58%-56.14%45.00%42.94%86.03%-38.63%
Free Cash Flow Growth (1y)FCF Growth (1y) 9.23%-15.43%21.78%
Free Cash Flow (QoQ)FCF (QoQ) -29.10%-9.66%62.74%-72.06%-64.17%25.69%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) -52.42%-417.90%-1,948.72%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ) 2,308.14%-105.39%26.35%-73.89%-191.35%
Net Cash Flow Growth (1y)NCF Growth (1y) 1,012.11%140.27%-79.50%
Net Cash Flow (QoQ)NCF (QoQ) -457.96%632.02%-160.24%151.01%-75.37%170.89%
Net Income Growth (1y) 21.62%-36.41%-50.18%-42.57%
Net Income (QoQ) -30.22%30.37%-56.72%44.84%-126.64%23.34%-48.78%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) 21.62%-36.41%-50.18%-42.57%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) -30.22%30.37%-56.72%44.84%-126.64%23.34%-48.78%
Operating Income Growth (1y)Op. Inc Growth (1y) 19.31%-38.51%-59.35%-51.76%
Operating Income (QoQ)Op. Inc (QoQ) -29.89%29.93%-52.97%42.04%-122.96%19.39%-45.68%
Profit After Tax Growth (1y)PAT Growth (1y) 21.62%-36.41%-48.89%-137.71%
Profit After Tax (QoQ)PAT (QoQ) -30.22%29.76%6.81%8.04%-126.64%23.34%-48.78%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) -25.04%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) 2.47%64.99%0.61%
Return on Assets [ROA] (QoQ)ROA (QoQ) 1,920.0075.00
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) 2,504.00-37.00
Return on Sales [ROS] Growth (1y)ROS Growth (1y) -39885.00
Return on Sales [ROS] (QoQ)ROS (QoQ) -49034.00-27630.00-11901.00
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) 834.25%-23.71%1,128.31%1,242.30%
Share-based Compensation (QoQ)Stock Comp. (QoQ) 1,271.57%-90.11%2.39%572.59%12.00%59.25%11.89%